Bumper Offer - Urjas oil Just @ Rs. 1
GRAFNOS 1MG CAPSULE is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Based on research, the following side effects have been observed when GRAFNOS 1MG CAPSULE is used -
Moderate
Mild
Is the use of GRAFNOS 1MG CAPSULE safe for pregnant women?
Pregnant women may experience moderate side effects from Grafnos . It is best to stop taking Grafnos immediately and inform your doctor if you notice any discomfort.
Is the use of GRAFNOS 1MG CAPSULE safe during breastfeeding?
Grafnos can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of GRAFNOS 1MG CAPSULE on the Kidneys?
Grafnos can have moderate side effects on the kidney. If you notice any harmful effects, stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of GRAFNOS 1MG CAPSULE on the Liver?
You may experience side effects on your liver after taking Grafnos . If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of GRAFNOS 1MG CAPSULE on the Heart?
Use of Grafnos may be dangerous for the heart. Do not use it without doctor's advice.
GRAFNOS 1MG CAPSULE should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take GRAFNOS 1MG CAPSULE unless your doctor advises you to do so -
Is this GRAFNOS 1MG CAPSULE habit forming or addictive?
GRAFNOS 1MG CAPSULE does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
Yes, it is safe to do these activities or work after taking GRAFNOS 1MG CAPSULE as it does not make you drowsy.
Is it safe?
Yes, but take GRAFNOS 1MG CAPSULE only as per medical advice.
Is it able to treat mental disorders?
No, the use of GRAFNOS 1MG CAPSULE in mental disorders is not effective.
Interaction between Food and GRAFNOS 1MG CAPSULE
Information is not available on the interaction of any foods with GRAFNOS 1MG CAPSULE, due to a lack of research on this.
Interaction between Alcohol and GRAFNOS 1MG CAPSULE
Consuming GRAFNOS 1MG CAPSULE with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Prograf® (tacrolimus)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 881
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1165-1167
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Prograf® (tacrolimus)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 881
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1165-1167
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Prograf® (tacrolimus)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 881
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1165-1167
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Prograf® (tacrolimus)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 881
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1165-1167
